$COTY

Luxury retailer exits beauty business and ends major partnership

Kering (PPRUY) said Gucci and L’Oréal (LRLCY) will start a 50-year exclusive beauty licensing deal in mid-2027, replacing Gucci’s current Coty (COTY) license that was set to run until June 30, 2028. Coty will receive about $400 million for early termination. Kering expects proceeds to support deleveraging after weaker performance, with net debt €9.5 billion at end-June 2025.

Original reporting
Published Jul 11, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 11, 2026, 1:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Luxury retailer exits beauty business and ends major partnership — source image
Decision brief

The 30-second read

$COTYNeutralMed
01

Why it matters

Kering’s early termination and sale accelerate the transition of Gucci beauty rights to L’Oréal, with defined compensation and transition cost sharing. For traders, the key is how the cash proceeds and royalty stream changes affect leverage, future cash flows, and segment profitability.

02

Market read

This is a concrete restructuring and licensing reallocation with multi-year timing and disclosed compensation amounts, which can reprice royalty expectations and leverage risk.

03

What to watch

The article does not break out expected incremental revenue or margin contribution for L’Oréal, nor the historical size of Gucci-linked royalties for Coty, which are key to translating the deal into earnings power.

Relevance 8/10Novelty 7/10Timing: deal announced July 11, 2026, with transition beginning mid-2027 and early termination payments in 2026-2027

Background

Kering launched Kering Beauté in 2023 after acquiring Creed, then planned to sell Kering Beauté to L’Oréal with a 50-year exclusive license for multiple brands; Gucci’s beauty rights were delayed due to Coty’s existing license.

Company-level read

Ticker impact

$COTYNeutralLow confidence
Context

Coty’s existing Gucci beauty license is replaced by L’Oréal’s new agreement, and Coty receives about $400 million for early termination.

Expected impact

Short-term could be supported by the cash compensation, but longer-term could be a headwind if Gucci royalties were material.

Evidence & confidence

The article provides the compensation figure and that Coty’s license is being replaced, but it does not quantify Coty’s historical Gucci royalty contribution or net margin impact, making direction and magnitude less certain.

Market effects

Signals continued consolidation of luxury beauty licensing, with L’Oréal expanding and fashion groups monetizing beauty assets to reduce leverage.

Primarily European luxury and consumer-beauty sentiment, with potential read-through to other licensing arrangements in Europe.

Long-term (50-year) brand licensing reinforces the global durability of luxury beauty demand and may influence how investors price royalty streams worldwide.

Counterpoint

The headline is balance-sheet improvement, but the market may discount the deal if proceeds are offset by restructuring costs, inventory write-downs, or weaker-than-expected beauty profitability.

Key entities

  • Kering Group

    Announces sale of its beauty business and early termination of Gucci beauty licensing, citing deleveraging and balance-sheet strengthening.

  • Gucci

    Fashion house whose beauty licensing is being replaced early, with new long-term rights granted to L’Oréal.

  • L’Oréal

    Secures a 50-year exclusive Gucci beauty licensing agreement starting mid-2027 and receives/structures transition economics.

  • Coty

    Receives compensation for early termination of its existing Gucci beauty license, which is replaced by L’Oréal’s agreement.

Related articles

$COTYMed

Analysis-No Gucci, no problem? Coty learns to live without flagship brand By Reuters

Reuters reports Coty will exit its Gucci Beauty licence a year early under a $400 million deal, returning the licence to Kering in mid-2027. Coty estimates it will forgo about $115 million annual adjusted EBITDA (15%), but expects $250 million upfront plus $150 million later to cut net debt (~$2.9B) and reduce costs. Barclays and analysts cite margin pressure but less Gucci dependence.

$COTYMed

Gucci Beauty License Shift to L’Oréal: Analysts Weigh Impact on Coty’s Future

Coty Inc. said it will end its Gucci Beauty fragrance and license early, with L’Oréal taking over a 50-year exclusive beauty license effective mid-2027. Coty will receive about $400 million in two payments ($250 million this year, up to $150 million in 2027). Analysts at Jefferies and Barclays weigh impacts on Coty’s EBITDA estimates and note the next update is due with Q4 earnings.

$COTYMedAI 8/10

Coty exits Gucci license early

Coty agreed to return the Gucci Beauty license to Kering about a year early for about $400 million, ending its current contract. Coty will use most proceeds to pay down debt and invest in brands like BOSS and Marc Jacobs. Deal terms include $250 million upfront, $150 million by Sept. 30, 2027, and up to $30 million incentives. Coty continues operating Gucci Beauty through June 30, 2027.

$COTYMed

Gucci and L'Oréal conclude a 50-year beauty licensing agreement

Kering said Gucci’s beauty licensing deal with Coty ends early, with Coty paying about $400 million. Kering will receive payments in 2026 ($250 million) and 2027 (up to $150 million). L’Oréal’s new Gucci beauty license is expected to start mid-2027, following a 2025 framework for L’Oréal to buy Kering’s beauty division for 4 billion euros.

$COTYMedAI 8/10

Coty Announces Agreement With Kering for Early Transition of Gucci Beauty License

Coty (NYSE: COTY) said it agreed with Kering to transition the Gucci Beauty license back to Kering about a year early. Coty will receive about $400 million, including $250 million at signing and $150 million by Sept. 30, 2027, plus a sale of inventory for the transition. Coty will run Gucci Beauty through at least June 30, 2027; proceeds will support debt paydown and reinvestment.